2 results
Approved WMORecruiting
Objective: To demonstrate the efficacy of a novel matrix therapy based technology that creates improved wound healing in a clinical donor site model.
Approved WMORecruiting
Compare the clinical efficacy of Epcoritamab to SOC (R-GemOx or BR)